BACKGROUND: There is marked variation in the use of the arteriovenous fistula (AVF) across programmes, regions and countries not explained by differences in patient demographics or comorbidities. The lack of clear criteria of who should or should not get a fistula may contribute to this, as well as barriers to creating AVFs. METHODS: We conducted a survey of Canadian and American nephrologists to assess the patient variables considered to determine the timing and type of access requested. Perceived barriers and absolute contraindications to access were also collected. RESULTS: An immediate referral for a fistula was more highly preferred when patients are <65 years old, have minimal comorbidities or have no history of failed accesses. In older patients, and in those with increased comorbidities or a previously failed fistula, US nephrologists selected arteriovenous grafts as an alternative to the fistula, while Canadian nephrologists selected primarily catheters. Referral for vascular mapping was more common in the USA than in Canada. Gender did not influence the timing or the type of access. Perceived barriers to establishing a mature fistula included patient refusal for creation (77%) or cannulation (58%), delay in decision regarding dialysis modality (71%), wait time for surgical creation (55%) and high failure-to-mature rate (52%). We found that 27% of Canadian and 43% of American nephrologists indicated no absolute contraindications for permanent vascular access. CONCLUSIONS: This study demonstrated marked variability in timing and criteria used to select patients for referral for a vascular access between nephrologists practicing within Canada and the USA. Establishing minimal eligibility criteria for fistulae is an important area of future research.
BACKGROUND: There is marked variation in the use of the arteriovenous fistula (AVF) across programmes, regions and countries not explained by differences in patient demographics or comorbidities. The lack of clear criteria of who should or should not get a fistula may contribute to this, as well as barriers to creating AVFs. METHODS: We conducted a survey of Canadian and American nephrologists to assess the patient variables considered to determine the timing and type of access requested. Perceived barriers and absolute contraindications to access were also collected. RESULTS: An immediate referral for a fistula was more highly preferred when patients are <65 years old, have minimal comorbidities or have no history of failed accesses. In older patients, and in those with increased comorbidities or a previously failed fistula, US nephrologists selected arteriovenous grafts as an alternative to the fistula, while Canadian nephrologists selected primarily catheters. Referral for vascular mapping was more common in the USA than in Canada. Gender did not influence the timing or the type of access. Perceived barriers to establishing a mature fistula included patient refusal for creation (77%) or cannulation (58%), delay in decision regarding dialysis modality (71%), wait time for surgical creation (55%) and high failure-to-mature rate (52%). We found that 27% of Canadian and 43% of American nephrologists indicated no absolute contraindications for permanent vascular access. CONCLUSIONS: This study demonstrated marked variability in timing and criteria used to select patients for referral for a vascular access between nephrologists practicing within Canada and the USA. Establishing minimal eligibility criteria for fistulae is an important area of future research.
Authors: Ronald L Pisoni; Eric W Young; Dawn M Dykstra; Roger N Greenwood; Erwin Hecking; Brenda Gillespie; Robert A Wolfe; David A Goodkin; Philip J Held Journal: Kidney Int Date: 2002-01 Impact factor: 10.612
Authors: Eric W Young; Dawn M Dykstra; David A Goodkin; Donna L Mapes; Robert A Wolfe; Philip J Held Journal: Kidney Int Date: 2002-06 Impact factor: 10.612
Authors: Jerry Avorn; Wolfgang C Winkelmayer; Rhonda L Bohn; Raisa Levin; Robert J Glynn; Elliot Levy; William Owen Journal: J Clin Epidemiol Date: 2002-07 Impact factor: 6.437
Authors: Ahmed A Al-Jaishi; Charmaine E Lok; Amit X Garg; Joyce C Zhang; Louise M Moist Journal: Clin J Am Soc Nephrol Date: 2015-01-07 Impact factor: 8.237
Authors: Charmaine E Lok; Jessica M Sontrop; George Tomlinson; Dheeraj Rajan; Mark Cattral; George Oreopoulos; Jeremy Harris; Louise Moist Journal: Clin J Am Soc Nephrol Date: 2013-01-31 Impact factor: 8.237
Authors: Tammy Hod; Bhanu K Patibandla; Yael Vin; Robert S Brown; Alexander S Goldfarb-Rumyantzev Journal: J Am Soc Nephrol Date: 2014-08-28 Impact factor: 10.121
Authors: Ranil N DeSilva; Bhanu K Patibandla; Yael Vin; Akshita Narra; Varun Chawla; Robert S Brown; Alexander S Goldfarb-Rumyantzev Journal: J Am Soc Nephrol Date: 2013-06-27 Impact factor: 10.121
Authors: Louise M Moist; Charmaine E Lok; Tushar J Vachharajani; Wang Xi; Ahmed AlJaishi; Kevan R Polkinghorne; Miguel Vazquez; Timmy C Lee Journal: Semin Dial Date: 2012 Nov-Dec Impact factor: 3.455